A recent study showed that SOCS1 pathogenic mutations confer reduced OS in R-CHOP-treated elderly DLBCL patients [114], which fits with the notion that SOCS1 mutations occur more frequently in relapsed DLBCL [34,51,53]. The gene discussed is SOCS1; the disease is diffuse large B-cell lymphoma.